Literature DB >> 2564726

Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.

E M Bednarczyk1, W B White, M A Munger, F M Gonzalez, E A Panacek, S G Weed, W F Rutherford, A R Nara, J A Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564726     DOI： 10.1016/0002-9149(89)90157-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

Review 1.  Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.

Authors:  R N Brogden; A Markham
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

2.  Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.

Authors:  K F Bodmann; S Tröster; R Clemens; H P Schuster
Journal:  Clin Investig       Date:  1993-12

Review 3.  Perioperative hypertension management.

Authors:  Joseph Varon; Paul E Marik
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.